BIOLOGICAL WRINKLE FILLER - LIPOSKILL
LIPOSKILL is wrinkle-filling product containing 100% autologous cells from the one’s own fat. It is a safe and fully-natural method that does not rely on injecting artificial components into the skin and instantly restores lost volume to the face for a natural look with a simple injection. It can be used all over the face, neck and neckline for such a treatments such as filling fine-to-deep wrinkles and deep skin breaks. It can also be used for cheek augmentation, nose reshaping, hands rejuvenation avoiding surgery, anesthesia, scalpel or stitches.
THE PROTOCOL
From only one harvest of 20ml of fat it is possible to obtain about 10 vials of cells that can be used for many fillers (the exact number of vials obtained is correlated with the characteristics of the fat tissue). The exclusive processes of Bioscience Laboratory guarantee the isolation and expansion of a homogeneous population of mesenchymal cells, following two protocols: the cryopreservation and the graft. In fact, cells may be used immediately to perform a treatment and can be frozen for future treatments. The newly activated cells go to work causing a dynamic regeneration response at the cellular level while filling the furrows caused by aging. Youthful beauty is restored by introducing millions of powerful new cells into the skin to eliminate facial lines, wrinkles, scars and replace lost skin volume.
WHY THE FAT?
It is known that fat tissue is amazingly rich source of Adipose Derived Cells which is very easy to harvest. ADC from your own fat speeds up the production of new cells and stimulates your tissue ability to repair itself. Damaged tissue cells causing lines , wrinkles and superficial imperfections are quickly outnumbered by the proliferation of healthy cells.
HOW DOES IT WORK?
Adipose Derived Cells contained in LIPOSKILL naturally restores lost volume by filling the wrinkles and feeds the skin enriching collagen and elastin which refurbishes the extra-cellular matrix. This natural product carries out filling using only autologous biological material and also stimulates cell regeneration due to cytokines and growth factors that are secreted by cells themselves. As proved by numerous scientific studies, ADC’s can produce vascularised and organised adipose tissue which doesn’t change its cellular structure and metabolic activity.
RESULTS
HOW DO THE RESULT LAST?
The conditions of application are the same as for all the fillers that are in the market with the important difference being, that the wrinkles are filled exclusively with one’s own cells and not with artificial components. The fillers that are on the market last until they are absorbed while LIPOSKILL lasts as long as the cells injected persist within the skin for a few years . Lastly it is important to mention that the effectiveness of the treatment is subject to genetic make-up, age and lifestyle.
STEP BY STEP PROCEDURE
From only one harvest of 20 mL of FAT it is possible to obtain about 10 vials of cells that can be used for many treatments. The exclusive processes of Bioscience guarantee the isolation and expansion of Adipose Derived Cells that may be used immediately to perform a treatment and can be frozen for future treatments.
INDICATIONS
∗ Glabellar Lines
∗ Lateral Brow
∗ Marionette Lines
∗ Nasolabial Fold
∗ Nose Reshaping
NATURAL BODY SHAPING – LIPOSKILL PLUS
BREAST AND BUTTOCKS AUGMENTATION WITH YOUR CELLS, WITHOUT SURGERY AND PROSTHESIS
Natural Breast and Buttocks augmentation and shaping of concave deformities without any permanent implants by a safe and quick treatment is possible. LIPOSKILL restores volume and contours body surfaces using hundreds of millions of expanded Adipose Derived Cells which are implanted using a scaffold consisting of autologous fat taken in advance.
TO AVOID SURGERY AND IMPLANTS
• Significantly reduces prolonged downtime and discomfort as well as the scarring and risks involved with all surgical procedures.
• Furthermore, eliminates many of the concerns patients have about surgery such as undergoing general anesthesia and potential scarring.
• Permanent implants typically involve major surgery under general anesthesia which can leave extensive scarring and is associated with other medical and surgical risks.
THE VOLUME ENHANCEMENT WITH AUTOLOGOUS CELLS
Unlike artificial implants, Adipose Derived Cells (ADC) in a natural fat scaffold allows more flexibility to shape and contour exactly the way you want, leading to a more personalized, natural-looking result. Many patients like the idea of using their own natural fat instead of introducing foreign materials into the body since there is a lower risk of infection or other complications. (Brayfield C, Marra K, Rubin JP. Adipose stem cells for soft tissue regeneration. Handchir Mikrochir Plast Chir. 2010).
THE PROCEDURE
The procedure consists of two phases: the first is taking the fat to extract and expand the fat cells. The second is collecting the fat to use as a scaffold that will be enriched with the expanded cells and then implanted.
By a withdrawal of fat of about 50-100 ml within 10 days, approximately 300 to 600 million cells are obtained.
Then, the expanded cells are combined with 100-200 ml of autologous fat and implanted to increase the volume. Thus obtaining a vascularized and organized panniculus adiposus which remains in the time.
STEP BY STEP PROCEDURE
Consists of two phases: the first is taking the FAT to extract and expand the ADCs. The second is collecting the FAT to use as a scaffold that will be enriched with the expanded cells and then implanted to increase the Volume.
ADVANTAGES OF A TREATMENT WITH LIPOSKILL
1. Get instant results with a tailor-made aesthetic treatment
2. Feel secure with a non-surgical and less invasive body shaping and body enhancement
3. Return quickly to daily activities without a post-treatment recovery period
4. Feel confident with a natural and safe material in your body
5. Cellular expansion is the only existing procedure in the world that allows the production of a significant amount of ADC for therapeutic purposes.
6. The sample can be taken via a simple micro-liposuction procedure, removing the need for surgery.
RESULTS
LIPOSKILL instantly restores volume to the breast and buttocks for a natural look with a simple injection treatment.
Individual results will depend on many factors, including the amount of fat available from donor sites and the increase in volume desired. The increase in volume that you get depends on the amount of fat that is used for the scaffold. (Stig-Frederik Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial Lancet 2013).
HOW LONG DO THE RESULTS LAST ?
The study done in vivo on humans, published on The Lancet 2013 has demonstrated that volume enhancement performed only with FAT (without expanded ADCs enrichment) is reduced by 86% in just four months. The same study demonstrates that the use of expanded ADCs limits the reduction of only 19% over the same period of time. Bioscience Institute Research & Development performed the same protocol as The Lancet study on their patients treated for breast augmentation and has demonstrated that after four months the volume reduction is only 10% (sometimes the residual volume was 100%).
The soft tissue augmentation with ADCs treatment feels more natural and similar to existing tissue. It was found that the tissue had the same kind of softness as the natural tissue, which makes it far more appealing. For breast augmentation the treatment expects to enhance the attractiveness of the breast by increasing the volume and texture of the tissues rather than lift it.
INDICATIONS
∗ Breast Augmentation
∗ Buttock Augmentation
∗ Penis Enlargement
∗ Cheek Augmentation
∗ Chin Augmentation
∗ Lips Enhancement
The Bioscience Institute laboratories carry out extraction, isolation, characterization, expansion and cryopreservation of (Adipose Derived Stem Cells) following standard operational procedures (SOP).
s are isolated starting from a fat tissue sample (about 10ml) which can be collected during a surgical liposuction or in one outpatient session.
The sample is transported to the Bioscience Institute laboratories in a special container.
The first part of the processing consists of the s from this sample, through enzymatic digestion.
The isolated cells are injected in flasks for cell culture and incubated at 37°C. The culture can be continued until the required number of cells is obtained and anyway not beyond the 4th stage of expansion.
The cells can be frozen at any stage in culture, but no more than twice, LIPOSKILL in fact foresees two protocols:
- Cryopreservation of stem cells extracted from the fat sample and potential grafts
- Immediate graft and potential cryopreservation
In this way it is possible to use the isolated fat stem cells for repeated treatments over the years according to patient needs.
Adipose Derived Stem Cells
Adipose Derived Stem Cells are mesenchymal stem cells found in the fat tissue; they constitute a multipotent cellular population which can differentiate into cells of various tissues, including bone, cartilage, heart and muscle.
Moreover, those cells have immunomodulating properties and an elevated capacity to retrieve and secrete angiogenic stimulating factors through endothelial cell retrieval and proliferation.
Adipose derived stem cells are also contained in the bone marrow, in the amniotic liquid and epithelial tissue.
Mesenchymal stem cells sampled from fat tissue () present the superficial markers typical of stem cells of mesenchymal nature. Such markers can be analyzed through flow cytofluorimetry, a technique which allows the measuring of individual physical and/or chemical characteristics of cells in suspension.
The main cellular lines into which the differentiate are:
AdipogenesisOsteogenesis
Chondrogenesis
Myogenesis
Haematopoietic and vascular uses
Some of the treated pathologies:
OsteoarthritisAutoimmune encephalomyelitis (EAE)
Refractory Chronic Autoimmune Thrombocytopenic Purpura
Complex perianal fistula
Rheumatoid arthritis
• Using your own cells prevents any risk of contagion so LIPOSKILL guarantees SAFE and NATURAL results
• Treatments are made with cells that are younger in age than the patient because the cryopreservation pauses the aging cells.
• No need to repeat collection of fat as the treatment may be repeated several times woth banked cells
• Quick return to daily activities without post-tretatment recovery period
| Date | Journal | Headline | Authors | Link |
|---|---|---|---|---|
| 2014 Jul | Am Heart J. | Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial. | Perin EC1, Sanz-Ruiz R2, Sánchez PL2, Lasso J3, Pérez-Cano R3, Alonso-Farto JC4, Pérez-David E2, Fernández-Santos ME5, Serruys PW6, Duckers HJ6, Kastrup J7, Chamuleau S8, Zheng Y1, Silva GV1, Willerson JT1, Fernández-Avilés F9. |  |
| 2014 Apr | Stem Cells Transl Med | Adipose stem cells used to reconstruct 13 cases with cranio-maxillofacial hard-tissue defects. | Sándor GK1, Numminen J, Wolff J, Thesleff T, Miettinen A, Tuovinen VJ, Mannerström B, Patrikoski M, Seppänen R, Miettinen S, Rautiainen M, Öhman J. | |
| 2014 Feb | Cytotherapy. | Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia. | Bura A1, Planat-Benard V2, Bourin P3, Silvestre JS4, Gross F5, Grolleau JL6, Saint-Lebese B7, Peyrafitte JA2, Fleury S2, Gadelorge M2, Taurand M2, Dupuis-Coronas S2, Leobon B8, Casteilla L9. | |
| 2013 Nov | Stem Cells. | Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn's fistula. | Lee WY1, Park KJ, Cho YB, Yoon SN, Song KH, Kim do S, Jung SH, Kim M, Yoo HW, Kim I, Ha H, Yu CS. | |
| 2013 Sep | Cytotherapy. | Pooled human platelet lysate versus fetal bovine serum-investigating the proliferation rate, chromosome stability and angiogenic potential of human adipose tissue-derived stem cells intended for clinical use. | Trojahn Kølle SF1, Oliveri RS, Glovinski PV, Kirchhoff M, Mathiasen AB, Elberg JJ, Andersen PS, Drzewiecki KT, Fischer-Nielsen A. | |
| 2013 Sep | Lancet. | Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial. | Kølle SF1, Fischer-Nielsen A, Mathiasen AB, Elberg JJ, Oliveri RS, Glovinski PV, Kastrup J, Kirchhoff M, Rasmussen BS, Talman ML, Thomsen C, Dickmeiss E, Drzewiecki KT. | |
| 2013 Jul | Plast Reconstr Surg. | Fat grafts supplemented with adipose-derived stromal cells in the rehabilitation of patients with craniofacial microsomia. | Tanikawa DY1, Aguena M, Bueno DF, Passos-Bueno MR, Alonso N. | |
| 2012 Mar | Appl Biochem Biotechnol. | The Impact of Long-Term In Vitro Expansion on the Senescence-Associated Markers of Human Adipose-Derived Stem Cells. | Safwani WK, Makpol S, Sathapan S, Chua KH. | |
| 2011 Oct | J Transl Med. | Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells | Jeong Chan Ra, et al. | |
| 2011 Sep | J Cell Mol Med. | Systemic transplantation of human adipose-derived stem cells stimulates bone repair by promoting osteoblast and osteoclast function | Lee K. et al. | |
| 2011 Aug | Tissue Cell. | Adipose-derived stromal cell transplantation for treatment of stress urinary incontinence | Wu G. et al | |
| 2011 Aug | Stem Cells Dev | Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans | Ra JC. et al | |
| 2011 Aug | Aesthet Surg J | Autologous fat transplantation versus adipose-derived stem cell-enriched lipografts: a study | Sterodimas A. et al | |
| 2011 Jul | Dermatol Surg. | Clinical trial of autologous differentiated adipocytes from stem cells derived from human adipose tissue | Kim M. et al | |
| 2011 Jun | J Med Case Reports. | Regeneration of human bones in hip osteonecrosis and human cartilage in knee osteoarthritis with autologous adipose-tissue-derived stem cells: a case series | Pak J. et al | |
| 2011 Apr | World J Stem Cells | Adipose-derived stromal cells: Their identity and uses in clinical trials, an update | Louis Casteilla, Valérie Planat-Benard, Patrick Laharrague, Béatrice Cousin | |
| 2011 Mar | Aesthetic Plast Surg. | Acellular Dermal Matrix Seeded with Adipose-Derived Stem Cells as a Subcutaneous Implant | Orbay H, Takami Y, Hyakusoku H, Mizuno H. | |
| 2011 Mar | Expert Opin Biol Ther | Hypoxia and adipose-derived stem cell-based tissue regeneration and engineering | Zachar V, Duroux M, Emmersen J, Rasmussen JG, Pennisi CP, Yang S, Fink T. | |
| 2011 Mar | Sem cells Dev | Human adipose-derived stromal cells efficiently support hematopoiesis in vitro and in vivo: a key step for therapeutic studies | DE Toni F, Poglio S, Ben Youcef A, Cousin B, Pflumio F, Bourin P, Casteilla L, Laharrague P. |
|
| 2011 Feb | Cell Transplant. | The effect of two and three dimensional cell culture on the chondrogenic potential of human adipose-derived mesenchymal stem cells after subcutaneous transplantation with an injectable hydrogel | Merceron C. et al. | |
| 2011 Feb | Ann Plast Surg | Adipose-derived stem cells for wound healing applications | Cherubino et al., | |
| 2011 Feb | Exp Dermatol | Adipose-derived stem cells as a new therapeutic modality for ageing skin. | Kim JH, Jung M, Kim HS, Kim YM, Choi EH. | |
| 2010 Dec | Stem Cells Int | Cotransplantation of adipose tissue-derived insulin-secreting mesenchymal stem cells and hematopoietic stem cells: a novel therapy for insulin-dependent diabetes mellitus | Vanikar AV. et al | |
| 2010 Dec | Surg Today | Human adipose-derived stem cells: Potential clinical applications in surgery. | Utsunomiya T, Shimada M, Imura S, Morine Y, Ikemoto T, Mori H, Hanaoka J, Iwahashi S, Saito Y, Iwaguro H. | |
| 2010 Sep | Stem Cells Dev. | Endothelial Differentiation of Adipose-Derived Stem Cells from Elderly Patients with Cardiovascular Disease. | Zhang P, Moudgill N, Hager E, Tarola N, Dimatteo C, McIlhenny S, Tulenko TN, Dimuzio P. | |
| 2010 Sep | J Plast Reconstr Aesthet Surg. | Regeneration potential and survival of transplanted undifferentiated adipose tissue-derived stem cells in peripheral nerve conduits. | Erba P, Mantovani C, Kalbermatten DF, Pierer G, Terenghi G, Kingham PJ. | |
| 2010 Sep | J Biomed Mater Res A | Application of different strain regimes in two-dimensional and three-dimensional adipose tissue-derived stem cell cultures induces osteogenesis: implications for bone tissue engineering. | Diederichs S, Böhm S, Peterbauer A, Kasper C, Scheper T, van Griensven M. | |
| 2010 Aug | Cytotherapy | Adipose tissue-derived stem cells show both immunogenic and immunosuppressive properties after chondrogenic differentiation. | Technau A, Froelich K, Hagen R, Kleinsasser N. | |
| 2010 Aug | Mol Imaging Biol. | Tracking Long-Term Survival of Intramyocardially Delivered Human Adipose Tissue-Derived Stem Cells Using Bioluminescence Imaging. | Bai X, Yan Y, Coleman M, Wu G, Rabinovich B, Seidensticker M, Alt E. | |
| 2010 Jul | Prostate | Effects of transplantation of adipose tissue-derived stem cells on prostate tumor. | Lin G, Yang R, Banie L, Wang G, Ning H, Li LC, Lue TF, Lin CS. | |
| 2010 Jun | Curr Stem Cell Res Ther. | Aesthetic cardiology: adipose-derived stem cells for myocardial repair. | Palpant NJ, Metzger JM. | |
| 2010 gun | Stem Cell Res Ther. | Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. | Gimble JM, Guilak F, Bunnell BA. | |
| 2010 May | Cell Biology International | Promotion of human adipose-derived stem cell proliferation mediated by exogenous nucleosides | Fernando Rodríguez-Serrano, Pablo Álvarez, Octavio Caba, Manuel Picón, Juan Antonio Marchal, Macarena Perán, José Prados, Consolación Melguizo, Ana Rosa Rama, Houria Boulaiz and Antonia Aránega | |
| 2010 May | Cell Biol Int. | Changes in the expression pattern of mesenchymal and pluripotent markers in human adipose-derived stem cells. | Park E, Patel AN. | |
| 2010 May | Biotechnol Bioeng. | Extent of cell differentiation and capacity for cartilage synthesis in human adult adipose-derived stem cells: Comparison with fetal chondrocytes | Mahmoudifar N, Doran PM. | |
| 2010 May | Cell Transplant | Adipocyte Transplantation and Stem Cells: Plastic Surgery Meets Regenerative Medicine | Tremolada C, Palmieri G, Ricordi C. | |
| 2010 Apr | Nature Reviews Endocrinology | Transplantation of adipose tissue and stem cells: role in metabolism and disease | Thien T. Tran & C. Ronald Kahn | |
| 2010 Mar | Short Communication | Adipose Tissue-Derived Mesenchymal Stem Cells Facilitate Hematopoiesis In Vitro and In Vivo. Advantages Over Bone Marrow-Derived Mesenchymal Stem Cells | Norihiko Nakao*, Takayuki Nakayama*, Takashi Yahata{dagger}, Yukari Muguruma{dagger}, Shigeki Saito*, Yasuhiko Miyata*, Koji Yamamoto{ddagger}, and Tomoki Naoe | |
| 2010 Mar | Case Report Med. | Adipose-derived stem cells in Crohn's rectovaginal fistula. | García-Olmo D, Herreros D, De-La-Quintana P, Guadalajara H, Trébol J, Georgiev-Hristov T, García-Arranz M. | |
| 2010 Mar | Breast J. | Progenitor-enriched adipose tissue transplantation as rescue for breast implant complications. | Yoshimura K, Asano Y, Aoi N, Kurita M, Oshima Y, Sato K, Inoue K, Suga H, Eto H, Kato H, Harii K. | |
| 2010 Mar | J Craniofac Surg. | In vivo cartilage formation using chondrogenic-differentiated human adipose-derived mesenchymal stem cells mixed with fibrin glue | Jung SN, Rhie JW, Kwon H, Jun YJ, Seo JW, Yoo G, Oh DY, Ahn ST, Woo J, Oh J. | |
| 2010 Feb | Mol Ther. | Adipose-derived stem cells as therapeutic delivery vehicles of an oncolytic virus for glioblastoma | Josiah DT, Zhu D, Dreher F, Olson J, McFadden G, Caldas H. | |
| 2010 Gen | Int J Urol. | Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy: report of two initial cases. | Yamamoto T, Gotoh M, Hattori R, Toriyama K, Kamei Y, Iwaguro H, Matsukawa Y, Funahashi Y. | |
| 2010 | Cytotherapy | Treatment of stress urinary incontinence with adipose tissue-derived stem cells. | Lin G, Wang G, Banie L, Ning H, Shindel AW, Fandel TM, Lue TF, Lin CS. | |
| 2009 Dic | J Plast Reconstr Aesthet Surg. | Tissue engineering with adipose-derived stem cells (s): current and future applications | Sterodimas A, de Faria J, Nicaretta B, Pitanguy I. | |
| 2009 Nov | J Craniofac Surg. | In vitro osteogenic differentiation of adipose stem cells after lentiviral transduction with green fluorescent protein. | Wang Q, Steigelman MB, Walker JA, Chen S, Hornsby PJ, Bohnenblust ME, Wang HT. | |
| 2009 Nov | Arterioscler Thromb Vasc Biol. | Adipose tissue-derived stem cells: characterization and potential for cardiovascular repair | Madonna R, Geng YJ, De Caterina R. | |
| 2009 Nov | ANZ J Surg. | Human adipose-derived stem cells: isolation, characterization and applications in surgery. | Caviggioli F, Vinci V, Salval A, Klinger M. | |
| 2009 Oct | J Tissue Eng Regen Med. | Culture effects of epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) on cryopreserved human adipose-derived stromal/stem cell proliferation and adipogenesis. | Hebert TL, Wu X, Yu G, Goh BC, Halvorsen YD, Wang Z, Moro C, Gimble JM. | |
| 2009 Aug | Lab Invest. | Differential expression of stem-cell-associated markers in human hair follicle epithelial cells | Inoue K, Aoi N, Sato T, Yamauchi Y, Suga H, Eto H, Kato H, Araki J, Yoshimura K. | |
| 2009 Aug | Rev Col Bras Cir. | Autologous mesenchymal stem cells culture from adipose tissue for treatment of facial rhytids | Claudio-da-Silva C. et al., | |
| 2009 Aug | Med Hypotheses | Local delivery of adipose-derived stem cells via acellular dermal matrix as a scaffold: a new promising strategy to accelerate wound healing | Nie C., et al | |
| 2009 Mar | Int J Oral Maxillofac Surg. | Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells | Mesimäki K. et al | |
| 2009 Mar | Regen Med. | Adipose-derived stem/progenitor cells: roles in adipose tissue remodeling and potential use for soft tissue augmentation. | Yoshimura K, Suga H, Eto H. | |
| 2009 Jan | Tissue Eng Part A. | Adipogenesis induced by human adipose tissue-derived stem cells | Tsuji W, Inamoto T, Yamashiro H, Ueno T, Kato H, Kimura Y, Tabata Y, Toi M. | |
| 2009 Jan | Int J Colorectal Dis. | Treatment of enterocutaneous fistula in Crohn's Disease with adipose-derived stem cells: a comparison of protocols with and without cell expansion | García-Olmo D. et al | |
| 2009 Jan | J Gastroenterol Hepatol | Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure | Banas A. et a | |
| 2009 Jan | Dis Colon Rectum. | Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial, | García-Olmo D. et al | |
| 2008 Sep | Dermatol Surg | Cell-assisted lipotransfer for facial lipoatrophy: efficacy of clinical use of adipose-derived stem cells | Yoshimura K. et al | |
| 2008 Apr | Hum Mol Genet | Cell-based therapies for skeletal regenerative medicine | Kwan MD, Slater BJ, Wan DC, Longaker MT. | |
| 2008 Jul | Exp Biol Med (Maywood) | Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue | Rebelatto CK, Aguiar AM, Moret�o MP, Senegaglia AC, Hansen P, Barchiki F, Oliveira J, Martins J, Kuligovski C, Mansur F, et all | |
| 2008 Jun | Stem Cells | Autocrine fibroblast growth factor 2 increases the multipotentiality of human adipose-derived mesenchymal stem cells | Rider DA, Dombrowski C, Sawyer AA, Ng GH, Leong D, Hutmacher DW, Nurcombe V, Cool SM. | |
| 2008 Jun | Cell Tissue Res | Effect of tissue-harvesting site on yield of stem cells derived from adipose tissue: implications for cell-based therapies | Jurgens WJ, Oedayrajsingh-Varma MJ, Helder MN, Zandiehdoulabi B, Schouten TE, Kuik DJ, Ritt MJ, van Milligen FJ. | |
| 2008 May | Transplant Proc | Human adipose tissue-derived mesenchymal stem cells combined with hematopoietic stem cell transplantation synthesize insulin | Trivedi HL, Vanikar AV, Thakker U, Firoze A, Dave SD, Patel CN, Patel JV, Bhargava AB, Shankar V. | |
| 2008 May | Ann Plast Surg | Regional anatomic and age effects on cell function of human adipose-derived stem cells | Schipper BM, Marra KG, Zhang W, Donnenberg AD, Rubin JP. | |
| 2008 Mar - Apr | Dermatol Ther | Esthetic and cosmetic dermatology | Wollina U, Goldman A, Berger U, Abdel-Naser MB. | |
| 2008 Apr | Biochem Biophys Res Commun | Mature adipocytes may be a source of stem cells for tissue engineering | Fernyhough ME, Hausman GJ, Guan LL, Okine E, Moore SS, Dodson MV. | |
| 2008 Apr | Biomaterials | Proliferation and differentiation of adipose-derived stem cells on naturally derived scaffolds | Flynn LE, Prestwich GD, Semple JL, Woodhouse KA. | |
| 2008 Apr | Biochem Biophys Res Commun | Mature adipocytes may be a source of stem cells for tissue engineering | Fernyhough ME, Hausman GJ, Guan LL, Okine E, Moore SS, Dodson MV. | |
| 2008 Apr | Biol Cell | Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro | Vieira NM, Brandalise V, Zucconi E, Jazedje T, Secco M, Nunes VA, Strauss BE, Vainzof M, Zatz M. | |
| 2008 Apr | Exp Cell Res | Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials | No�l D, Caton D, Roche S, Bony C, Lehmann S, Casteilla L, Jorgensen C, Cousin B. | |
| 2008 Mar | Ann Plast Surg | Role of gender and anatomical region on induction of osteogenic differentiation of human adipose-derived stem cells | Aksu AE, Rubin JP, Dudas JR, Marra KG. | |
| 2008 Mar | Panminerva Med | Differentiation of embryonic and adult stem cells into insulin producing cells | Zulewski H. | |
| 2008 Mar | Transplant Proc | Hepatocytes derived from adult stem cells | Stock P, Staege MS, M�ller LP, Sgodda M, V�lker A, Volkmer I, L�tzkendorf J, Christ B. | |
| 2008 Mar | J Can Dent Assoc | Combining adipose-derived stem cells, resorbable scaffolds and growth factors: an overview of tissue engineering | S�ndor GK, Suuronen R. | |
| 2008 Feb | Stem Cells | Adipose-derived stem cells are a source for cell therapy of the corneal stroma | Arnalich-Montiel F, Pastor S, Blazquez-Martinez A, Fernandez-Delgado J, Nistal M, Alio JL, De Miguel MP. | |
| 2008 Feb | BMC Mol Biol | Characterization of human mesenchymal stem cell secretome at early steps of adipocyte and osteoblast differentiation | Chiellini C, Cochet O, Negroni L, Samson M, Poggi M, Ailhaud G, Alessi MC, Dani C, Amri EZ. | |
| 2008 | Biomed Mater Eng | Comparing mesenchymal stromal cells from different human tissues: bone marrow, adipose tissue and umbilical cord blood | Bieback K, Kern S, Koca�mer A, Ferlik K, Bugert P. | |
| 2008 | Methods Cell Biol | Isolation of human mesenchymal stem cells from bone and adipose tissue. | Bernacki SH, Wall ME, Loboa EG. | |
| 2008 | Cells Tissues Organs | Human adipose stem cells: a potential cell source for cardiovascular tissue engineering | Heydarkhan-Hagvall S, Schenke-Layland K, Yang JQ, Heydarkhan S, Xu Y, Zuk PA, MacLellan WR, Beygui RE. | |
| 2008 | Dermatol Surg | Adipose-derived stem cells and their secretory factors as a promising therapy for skin aging. | Park et al | |
| 2008 | Methods Mol Biol | Adipose-derived stem cells | Fraser JK, Zhu M, Wulur I, Alfonso Z. | |
| 2007 Dic | Transplant Proc. | Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease | Fang B. et al | |
| 2007 Nov | Pediatr Transplant | Human adipose tissue-derived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft-vs.-host disease in two children | Fang B. et al | |
| 2007 Mar - Apr | J Tissue Eng Regen Med | Osteogenic differentiation of human adipose-derived stem cells: comparison of two different inductive media | de Girolamo L, Sartori MF, Albisetti W, Brini AT. | |
| 2007 Jan | Bull Exp Biol Med | Umbilical cord blood mesenchymal stem cells | Musina RA, Bekchanova ES, Belyavskii AV, Grinenko TS, Sukhikh GT. | |
| 2007 | Cell Physiol Biochem | Direct comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia | Kim Y, Kim H, Cho H, Bae Y, Suh K, Jung J. | |
| 2007 | Cell Transplant | Adipose-derived cells | Meliga E, Strem BM, Duckers HJ, Serruys PW. | |
| 2006 Sep | Curr Stem Cell Res Ther | Adult mesenchymal stem cells: a pluripotent population with multiple applications | Porada CD, Zanjani ED, Almeida-Porad G. | |
| 2006 Sep | Curr Stem Cell Res Ther | Adult stem cells in bone and cartilage tissue engineering | Salgado AJ, Oliveira JT, Pedro AJ, Reis RL. | |
| 2005 Jul | Dis Colon Rectum. | A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation | García-Olmo D. et al. | |
| 2005 Jan | Curr Stem Cell Res Ther | The importance of adipose-derived stem cells and vascularized tissue regeneration in the field of tissue transplantation | Ogawa R. | |